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Abstract
Background: The use of cardiac output monitoring may improve patient outcomes after major surgery. However,
little is known about the use of this technology across nations.
Methods: This is a secondary analysis of a previously published observational study. Patients aged 16 years and
over undergoing major non-cardiac surgery in a 7-day period in April 2011 were included into this analysis. The
objective is to describe prevalence and type of cardiac output monitoring used in major surgery in Europe.
Results: Included in the analysis were 12,170 patients from the surgical services of 426 hospitals in 28 European
nations. One thousand four hundred and sixteen patients (11.6 %) were exposed to cardiac output monitoring, and
2343 patients (19.3 %) received a central venous catheter. Patients with higher American Society of Anesthesiologists
(ASA) scores were more frequently exposed to cardiac output monitoring (ASA I and II, 643 patients [8.6 %]; ASA III–V,
768 patients [16.2 %]; p < 0.01) and central venous catheter (ASA I and II, 874 patients [11.8 %]; ASA III–V, 1463 patients
[30.9 %]; p < 0.01). In elective surgery, 990 patients (10.8 %) were exposed to cardiac output monitoring, in urgent
surgery 252 patients (11.7 %) and in emergency surgery 173 patients (19.8 %). A central venous catheter was used in
1514 patients (16.6 %) undergoing elective, in 480 patients (22.2 %) undergoing urgent and in 349 patients (39.9 %)
undergoing emergency surgery. Nine hundred sixty patients (7.9 %) were monitored using arterial waveform analysis,
238 patients (2.0 %) using oesophageal Doppler ultrasound, 55 patients (0.5 %) using a pulmonary artery catheter
and 44 patients (2.0 %) using other technologies. Across nations, cardiac output monitoring use varied from 0.0 %
(0/249 patients) to 27.5 % (19/69 patients), whilst central venous catheter use varied from 5.6 % (7/125 patients) to
43.2 % (16/37 patients).
Conclusions: One in ten patients undergoing major surgery is exposed to cardiac output monitoring whilst one in
five receives a central venous catheter. The use of both technologies varies widely across Europe.
Trial registration: ClinicalTrials.gov Identifier: NCT01203605. Date of registration: 15.09.2010.
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Background
More than 312 million surgical procedures are per-
formed worldwide each year with an estimated mor-
tality between 1 and 4 % [1, 2]. Postoperative
complications and death are most frequent amongst
high-risk patients, who are older, have co-morbid dis-
ease and undergo major surgery [3]. The dose of
intravenous fluid and vasoactive drugs has an import-
ant effect on patient outcomes following major
gastrointestinal surgery [4]. These treatments are pre-
scribed according to subjective criteria leading to
wide variation in clinical practice [5–9]. One potential
solution to this problem is the use of cardiac output
monitoring to guide administration of intravenous
fluid and vasoactive drugs [4].
The use of perioperative cardiac output monitoring re-
mains controversial, with differing interpretations of the
evidence base for this treatment approach [10–18]. Re-
cent evidence from a large clinical trial suggests that the
benefit associated with this technology may be more
marginal than previously believed, whilst some commen-
tators have raised safety concerns [4, 19, 20]. Cardiac
output monitoring has been recommended for patients
undergoing selected types of major surgery both by the
National Institute for Health and Care Excellence
(NICE) in the UK and in a report commissioned by the
Centers for Medicare and Medicaid Services in the USA
[21, 22]. However, clinician surveys and anecdotal evi-
dence suggest there is wide variation in the use of this
technology [6–9].
Across Europe, little is known about the use of cardiac
output monitoring in non-cardiac surgery. A previously
published 7-day cohort study described mortality and
perioperative care in 28 European nations (European
Surgical Outcomes Study [EuSOS]) [2]. Data were col-
lected which describe the use of cardiac output monitor-
ing and central venous catheterisation. We performed a
secondary analysis of the EuSOS dataset to describe
the prevalence and types of cardiac output monitoring
in patients undergoing major surgery across European
nations.
Methods
Ethics
Ethics requirements differed by country. In Denmark,
centres were exempt from ethics approval as the
study was deemed to be a clinical audit. In all other
nations, formal ethics approval was obtained. For the
United Kingdom, approval was given by the Oxfordshire
Research Ethics Committee B (Harrow, United Kingdom,
15th November 2010, chair Prof. M. Rees, reference num-
ber 10/H0605/72). In Finland, informed consent was ob-
tained for all participants as required by the ethics
committee.
Setting
This is a secondary analysis of the previously pub-
lished European Surgical Outcomes Study, a 7-day
observational cohort study including consecutive pa-
tients undergoing inpatient non-cardiac surgery in
April 2011 [2].
Data collection
Eligible for EuSOS were consenting patients aged
16 years and over undergoing inpatient non-cardiac sur-
gery, irrespective of the chosen anaesthetic technique.
We excluded patients undergoing planned day-case sur-
gery, cardiac surgery, neurosurgery, radiological or ob-
stetric procedures. From this dataset, we only included
patients undergoing major surgery (duration more than
90 min as defined in the EuSOS protocol) in this ana-
lysis. Use of haemodynamic monitoring in the operating
room was recorded on a paper case record form in the
following categories: central venous catheter, arterial
waveform analysis (including both calibrated and uncali-
brated analysis), oesophageal Doppler ultrasound, pul-
monary artery catheter and other. Data were assessed
for completeness and checked for plausibility and
consistency. A list of participating hospitals and full de-
tails of the methodology of the study can be found in
the original publication [2].
Statistical analysis
A descriptive analysis was carried out according to a
prospectively written statistical analysis plan. Data are
presented as mean (standard deviation) for continuous
variables and absolute or relative frequencies as percent-
ages for categorical variables. Baseline characteristics of
patient groups were tabulated and differences between
groups compared using Pearson’s chi-square (χ2) test or
t-test as appropriate. Prevalence of each type of haemo-
dynamic monitoring was assessed per urgency of sur-
gery, surgical speciality and per nation. Countries with
less than ten recruited patients were excluded from
graphs presenting per nation data. All analysis was car-
ried out using STATA MP 13.1 (STATA Corp, USA).
Results
Baseline characteristics
From the original EuSOS dataset (46,539 patients), we
excluded 34,349 patients who did not undergo major
surgery and 20 patients for missing haemodynamic mon-
itoring data. In total, 12,170 patients who underwent
major surgery in 426 hospitals from 28 countries were
included into this analysis. The patient flow diagram is
available as an additional online file (Additional file 1:
Figure S1). Baseline characteristics of patients are pre-
sented in Table 1 according to exposure to cardiac out-
put monitoring and central venous catheter (CVC).
Ahmad et al. Perioperative Medicine  (2015) 4:8 Page 2 of 7
Use of haemodynamic monitoring
One thousand four hundred and sixteen patients
(11.6 %) were exposed to cardiac output monitoring, and
2343 (19.3 %) patients received a CVC. Six hundred
eighty (5.6 %) patients received both cardiac output
monitoring and a CVC. Patients exposed to cardiac
Table 1 Baseline characteristics of patients without/with cardiac output monitoring and with central venous catheter
All Without cardiac output
monitoring
With cardiac output
monitoring
p* With central venous catheter
Age <0.01
Mean (SD) 61.7 (16.5) 61.4 (16.6) 63.6 (15.2) 62.9 (15.0)
Gender <0.01
Male 6290 (51.7 %) 5706 (90.7 %) 584 (9.3 %) 935 (14.9 %)
Female 5878 (48.3 %) 5048 (85.9 %) 830 (14.1 %) 1407 (23.9 %)
Current smoker 2329 (19.3 %) 2041 (19.1 %) 288 (20.5 %) 0.20 527 (22.7 %)
ASA Score <0.01
I and II 7400 (60.8 %) 6793 (91.4 %) 643 (8.6 %) 874 (11.8 %)
III, IV and V 4736 (39.0 %) 3978 (84.0 %) 768 (16.2 %) 1463 (30.9 %)
Urgency of surgery <0.01
Elective 9132 (75.1 %) 8142 (89.2 %) 990 (10.8 %) 1514 (16.6 %)
Urgent 2161 (17.8 %) 1909 (88.3 %) 252 (11.7 %) 480 (22.2 %)
Emergency 875 (7.2 %) 702 (80.2 %) 173 (19.8 %) 349 (39.9 %)
Surgical speciality <0.01
Orthopaedic 3984 (32.8 %) 3800 (95.4 %) 184 (4.6 %) 175 (4.4 %)
Breast 350 (2.9 %) 331 (94.6 %) 19 (5.4 %) 32 (9.2 %)
Gynaecology 1051 (8.7 %) 1005 (95.6 %) 46 (4.4 %) 70 (6.7 %)
Vascular 807 (6.7 %) 633 (78.4 %) 174 (21.6 %) 267 (33.3 %)
Gastrointestinal 2717 (22.3 %) 2144 (78.9 %) 573 (21.1 %) 971 (35.7 %)
Hepato-biliary 510 (4.2 %) 370 (72.6 %) 140 (27.5 %) 299 (58.6 %)
Plastic or cutaneous 192 (1.6 %) 188 (97.9 %) 4 (2.1 %) 22 (11.5 %)
Urology and kidney 1219 (10.0 %) 1073 (87.1 %) 146 (12.9 %) 266 (28.2 %)
Head and neck 684 (5.6 %) 638 (93.3 %) 46 (6.7 %) 64 (9.4 %)
Other 622 (5.1) 542 (87.1 %) 80 (12.9 %) 167 (26.9 %)
Co-morbid disorder
No co-morbid disorder 6679 (54.9 %) 6095 (91.2 %) 584 (8.7 %) <0.01 918 (13.7 %)
Cirrhosis 186 (1.5 %) 126 (67.7 %) 60 (32.3 %) <0.01 97 (52.2 %)
Congestive heart failure 646 (5.3 %) 519 (80.3 %) 127 (19.7 %) <0.01 196 (30.3 %)
COPD 1590 (13.1 %) 1352 (85.0 %) 238 (15.0 %) <0.01 388 (24.4 %)
Coronary artery disease 1999 (16.5 %) 1685 (84.3 %) 314 (15.7 %) <0.01 460 (23.1 %)
NIDDM 1119 (9.2 %) 973 (87.0 %) 146 (13.1 %) 0.12 245 (21.9 %)
Metastatic cancer 1014 (8.4 %) 815 (80.4 %) 199 (19.6 %) <0.01 421 (41.5 %)
Stroke 719 (5.9 %) 601 (83.6 %) 118 (16.4 %) <0.01 172 (23.9 %)
Hospital statistics
Length of hospital stay (mean, SD) 8.9 (9.4) 8.5 (9.3) 12.4 (12.0) <0.01 15.0 (12.9)
ICU admission 2534 (20.8 %) 1900 (17.7 %) 634 (44.8 %) <0.01 1445 (61.7 %)
Mortality 667 (5.5 %) 535 (5.0 %) 142 (10.0 %) <0.01 287 (12.2 %)
Total 12 170 10,754 (88.4 %) 1416 (11.6 %) 2343 (19.3 %)
Data presented as mean (SD) or n (%)
ASA American Society of Anesthesiologists, ICU intensive care unit, NIDDM non-insulin-dependent diabetes mellitus, COPD chronic obstructive pulmonary disease
*p value describes comparison of the patient groups with and without cardiac output monitoring
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output monitoring or central venous catheterisation had
higher American Society of Anesthesiologists (ASA)
scores, were slightly older and more likely to undergo
urgent or emergency surgery (Table 1). Patients receiv-
ing cardiac output monitoring or a CVC had a longer
hospital stay, were more likely to be admitted to inten-
sive care and were more likely to die than patients who
did not receive cardiac output monitoring (Table 1).
Nine hundred sixty patients (7.9 %) were monitored
using arterial waveform analysis, 238 (2.0 %) using
oesophageal Doppler ultrasound, 55 patients (0.5 %)
using a pulmonary artery catheter and 44 patients
(2.0 %) using another technology. Arterial waveform
analysis was the most frequently used technique across
urgencies of surgery (Fig. 1), surgical specialities (Fig. 2)
and nations. Country-level data describing the use of dif-
ferent monitoring techniques is available as an additional
online file (see Additional file 1: Figure S2 and Table S1).
Across European nations, cardiac output monitoring use
varied from 0.0 % (0/249 patients) to 27.5 % (19/69 pa-
tients) and the use of CVC from 5.6 % (7/125 patients)
to 43.2 % (16/37 patients) (Fig. 3).
Discussion
The principal finding of this analysis was that one in ten
patients undergoing major surgery is exposed to cardiac
output monitoring and one in five patients receives a
CVC. Cardiac output monitoring and CVC use were
more frequent with increasing ASA score and increasing
urgency of surgery. The use of both cardiac output
monitoring and CVCs was associated with a longer
hospital stay, more admissions to critical care and
higher mortality. Importantly, there was wide variation
in the use of cardiac output monitoring and CVCs
across European nations. The most commonly used
method of cardiac output monitoring was arterial
waveform analysis.
There is very little published patient-level data describ-
ing the use of cardiac output monitoring either in indi-
vidual countries or at an international level. However,
questionnaire-based surveys amongst anaesthesiologists
have been used to explore the use of cardiac output
monitoring in high-risk surgical patients. The most
widely cited of these is an online questionnaire survey
conducted in 2011 by Cannesson et al. amongst mem-
bers of the American Society of Anesthesiologists and
the European Society of Anaesthesiology. From 368 re-
spondents, 35 % routinely monitored cardiac output
with similar numbers in Europe and in North America
[6]. A similar survey of members of the Korean Society
of Anesthesiologists revealed that 59 % of 139 respon-
dents were using cardiac output monitoring [8]. The
findings of a paper-based survey of Chinese anaesthetists
showed that cardiac output monitoring was used by
13 % of 210 respondents [9]. In addition to the vari-
ation in use of cardiac output monitoring, these
surveys also reveal differences in the monitoring tech-
nique used. This variability is supported by another
online questionnaire-based survey, exploring the use
of goal-directed therapy in major elective surgery
amongst members of the Association of Anaesthetists
of Great Britain and Ireland, the American Society of
Anesthesiologists and the Australia and New Zealand
College of Anaesthetists [7]. Overall, the findings of these
clinician surveys are consistent with the findings of our
analysis of patient-level data. The lower use of cardiac out-
put monitoring in our data compared to the data provided
by Cannesson et al. might be due to the broader inclusion
criteria of our study [6]. Suggested explanations for the
wide variation in clinical practice were local factors
Fig. 1 Use of cardiac output monitoring and central venous catheter per urgency of surgery. Data displayed as percentage per urgency of
surgery. AWF arterial waveform analysis, Doppler Doppler ultrasound, PAC pulmonary artery catheter, COM cardiac output monitoring, CVC central
venous catheter
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Fig. 2 Use of cardiac output monitoring and central venous catheter overall and per surgical speciality. Data displayed as percentage overall/per
surgical speciality. AWF arterial waveform analysis, Doppler Doppler ultrasound, PAC pulmonary artery catheter, COM cardiac output monitoring,
CVC central venous catheter
Fig. 3 Variation in use of cardiac output monitoring and central venous catheter in European nations. Data is presented in % of patients with any
type of cardiac output monitoring (bar) and central venous catheter (black diamond) per nation. Only nations with more than ten recruited
patients are included into this graph. UK United Kingdom
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including availability of equipment, experience or educa-
tion and national factors like reimbursement and
guidelines [6, 21–23]. Involvement of clinicians in the
development of, and therefore familiarity with, a certain
device may also provide another explanation, which is
why, for example, the use of PiCCO (PULSION Medical
Systems, Germany) or LiDCO (LiDCO Ltd., United
Kingdom) seems to be focused on their country of
origin [6]. In addition, involvement of national opinion
leaders in clinical trials improving the evidence base for
certain devices might have contributed to the more exten-
sive use of oesophageal Doppler monitoring in the United
Kingdom compared to other nations [24–26]. Scepticism
regarding possible benefits and harms is seen as another
important contributor [6]. This in view of studies which
suggested that fluid restriction might be equally beneficial
as fluid optimization [19, 27, 28].
To our knowledge, this is the largest available patient
dataset describing the use of haemodynamic monitoring
across international boundaries. However, the study only
provides evidence of activity in one 7-day period in par-
ticipating centres and so may not provide an accurate
reflection of activity over a longer time frame. The data
were collected 4 years ago, and contemporary practice
may have evolved since the original study. The small
number of patients returned by a small number of hos-
pitals in smaller countries may also have resulted in bias
and a poor representation of patterns of monitoring use
within those countries. In addition, the small patient
numbers in some sub-categories limit the robustness of
any analysis of variation between hospitals or potential
clustering within hospitals, especially as some centres
may specialise in particular types of surgery with conse-
quent effects on care pathways and case mix. The study
was not specifically designed for collection of data de-
scribing the use of haemodynamic monitoring and did
not provide precise detail on the specific product used
in each patient. No data were collected to describe how
haemodynamic data were used, the target values for spe-
cific variables or which interventions were used to attain
these targets. In addition, there is no data describing the
indication for CVC placement. Due to the heterogeneity
of cases and the limited sample size, we were not able to
further analyse effects of haemodynamic monitoring on
clinical outcomes.
Conclusions
One in ten patients undergoing major surgery in Europe
is exposed to cardiac output monitoring whilst one in
five receives a central venous catheter. The use of both
technologies varies widely across nations. Further re-
search is needed to confirm the clinical value of cardiac
output monitoring and how this technology might help
to further reduce postoperative morbidity and mortality.
Additional file
Additional file 1: Supplemental digital content. Patient flow diagram
(supplementary Figure 1), variation in the use of different types of
cardiac output monitoring in European nations (supplementary Figure 2)
and types of haemodynamic monitoring used in European nations
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